MPP Logo
Twitter LinkedIn YouTube
Search
English / Français
Ethics Portal
Twitter LinkedIn YouTube
Search
English / Français
Ethics Portal
  • Who We Are
    • About Us
    • Business Model
    • Our Strategy 2023-2025
    • Statutes, By-Laws & Policies
    • Governance & Team
    • Annual Reports
    • Careers & RFPs
  • What We Do
    • Licensing for Public Health
    • mRNA Technology Transfer Programme
    • Prioritising Medicines for Licensing
    • Disease Areas
    • Focus areas
      • Biotherapeutics
      • Local and Regional Production
      • Pandemic Preparedness and Response
      • Regulatory Access
      • Technology Transfer
      • Upstream Access
    • Addressing Children’s Needs
    • Patent Information Tools
      • MedsPaL
      • LAPaL
    • Long-Acting Therapeutics
  • Progress
    • Prioritisation
    • Licences
    • Access to Medicines Tracker
    • Contribution to Universal Health Coverage
    • Endorsements
    • Impact
  • News & Publications
    • News, Events & Press Releases
    • Messages from the Executive Director
    • MPP in the Media
    • MPP Publications
    • Related Publications
    • Newsletters & Updates
  • Partners
    • Partnering with MPP
    • Our Stories
      • Kenya
      • Ukraine
      • India
      • Voices from Friends of MPP
    • Funders
    • How to Give or Get a Licence
  • Contact Us

Stories

"I’m in my fourth month of treatment and I would say of course I am more hyper, I’m no longer lethargic, I no longer dread taking my pill at 10:00 PM at night."

people » Stories

Jacqueline Wambui

22 March 2020

MPP Logo

Subscribe to our Newsletter

Subscribe to our Newsletter

Subscribe

* indicates required






The Medicines Patent Pool will use the information (email address) you provide on this form to be in touch with you and to provide updates.


You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at press@medicinespatentpool.org. We will treat your information with respect. For more information about our privacy practices, please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.


About Us
Licences
MedsPaL
Careers & RFPs
Contact

Founded & funded by

Unitaid Logo

Other funders